{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-019604","form_type":"8-K","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2023-05-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.901127+00:00","generated_at":"2026-06-14T15:37:39.188735+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Cumberland Pharmaceuticals dismisses FORVIS as auditor, appoints CRI for FY2023","bullets":["Effective May 18, 2023, dismissed FORVIS as independent auditor; new auditor is Carr, Riggs & Ingram (CRI) subject to engagement letter.","No disagreements on accounting principles, financial statement disclosure, or audit scope during 2021-2022 and interim 2023.","FORVIS audit reports for 2021 and 2022 were unqualified, no adverse opinion or modification.","Company provided FORVIS with disclosures; FORVIS furnished letter to SEC agreeing with statements (Exhibit 16.1).","No consultations with CRI regarding accounting principles or disagreements prior to appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-019604","json":"https://secwatch.observer/filing/0001628280-23-019604.json","markdown":"https://secwatch.observer/filing/0001628280-23-019604.md","text":"https://secwatch.observer/filing/0001628280-23-019604.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000162828023019604/0001628280-23-019604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000162828023019604/cpix-20230524.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T15:37:39.188735+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}